Furmecil 15/4.35/11.8Mg Cap 7'S

Furmecil 15/4.35/11.8Mg Cap is indicated in the treatment of stomach/gastric cancer. Stomach (gastric) cancer is a type of cancer that originates in the cells lining the stomach. Symptoms may include feeling bloated after eating, nausea, heartburn or indigestion.

Furmecil 15/4.35/11.8Mg Cap contains Tegafur, Gimeracil and Oteracil, which work by inhibiting the genetic material and preventing the growth of cancer cells. Thereby, it helps treat stomach cancer.

In some cases, Furmecil 15/4.35/11.8Mg Cap may cause side effects such as nausea, vomiting, diarrhoea, and constipation. Do not be reluctant to talk with your doctor if any of the side effects persist or worsen.

Do not use Furmecil 15/4.35/11.8Mg Cap if you are pregnant or breastfeeding. Furmecil 15/4.35/11.8Mg Cap is not recommended for children as safety and effectiveness have not been established. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

Furmecil 15/4.35/11.8Mg Cap is used in the treatment of gastric/stomach cancer. The detailed use of Furmecil 15/4.35/11.8Mg Cap is as follows:

• Advanced gastric (stomach) cancer: Furmecil 15/4.35/11.8Mg Cap is used in the treatment of Advanced gastric (stomach) cancer.

• Furmecil 15/4.35/11.8Mg Cap can be taken 1 hour before or after a meal.
• It is usually taken 2 times a day, in the morning and evening, for the duration prescribed by your doctor.
• Swallow Furmecil 15/4.35/11.8Mg Cap as a whole with a glass of water.
• Do not crush, chew, or open it.

Furmecil 15/4.35/11.8Mg Cap is indicated in the treatment of stomach/gastric cancer. Furmecil 15/4.35/11.8Mg Cap contains Tegafur, Gimeracil and Oteracil. Tegafur is converted into the active drug 5FU (fluorouracil) in the liver and then absorbed by tumour cells. It inhibits the synthesis of genetic material (DNA and RNA) and prevents the growth of cancer cells. Gimeracil prevents the degradation of 5FU, and Oteracil inhibits the gastrointestinal toxicity of 5FU. Together, Furmecil 15/4.35/11.8Mg Cap helps treat stomach cancer.

Do not take Furmecil 15/4.35/11.8Mg Cap if you are allergic to any of its components, if you are pregnant or breastfeeding, if you have a history of severe and unexpected reactions to fluoropyrimidine therapy, known dihydropyrimidine dehydrogenase (DPD) deficiency, severe bone marrow suppression, or end-stage renal disease requiring dialysis. Inform the doctor if you have bone marrow suppression, diarrhoea, dehydration, kidney or liver problems, or eye toxicity. Furmecil 15/4.35/11.8Mg Cap is not recommended for use in children below 18 years. Let the doctor know if you take other medicines, including supplements and herbal products.